APA

van Bezooijen R. L., Roelen B. A. J., Visser A., van der Wee-Pals L., de Wilt E., Karperien M., Hamersma H., Papapoulos S. E., ten Dijke P. & Löwik C. W. G. M. (20040916). Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. : The Journal of experimental medicine.

Chicago

van Bezooijen Rutger L, Roelen Bernard A J, Visser Annemieke, van der Wee-Pals Lianne, de Wilt Edwin, Karperien Marcel, Hamersma Herman, Papapoulos Socrates E, ten Dijke Peter and Löwik Clemens W G M. 20040916. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. : The Journal of experimental medicine.

Harvard

van Bezooijen R. L., Roelen B. A. J., Visser A., van der Wee-Pals L., de Wilt E., Karperien M., Hamersma H., Papapoulos S. E., ten Dijke P. and Löwik C. W. G. M. (20040916). Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. : The Journal of experimental medicine.

MLA

van Bezooijen Rutger L, Roelen Bernard A J, Visser Annemieke, van der Wee-Pals Lianne, de Wilt Edwin, Karperien Marcel, Hamersma Herman, Papapoulos Socrates E, ten Dijke Peter and Löwik Clemens W G M. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. : The Journal of experimental medicine. 20040916.